Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology
Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology ultrasound scanner (SCAN10/24/90).
Siemens would have had international rights to market thescanner once it was developed. Interspec retains worldwide rightsto the technology developed cooperatively. The smaller firm plansto sell the system itself through a combination of direct salesand distribution agreements, according to Edward Ray, chairmanand CEO.
"Interspec will take advantage of this opportunity andexpand its established international distribution to market itsnew product when it becomes available," Ray said.
Study: AI Bolsters Sensitivity for Pneumothorax on CXR and Significantly Reduces Reporting Time
October 30th 2024For clinically actionable pneumothorax, an artificial intelligence algorithm demonstrated a 93 percent AUC and a 96 percent specificity rate in a study involving chest X-rays from over 27,000 adults.
AI Segmentation, Intraprostatic Tumor Volume and Metastases: What a New mpMRI Study Reveals
October 29th 2024For patients who received radiotherapy for localized prostate cancer, total intraprostatic tumor volume derived from AI segmentation had a 10 percent higher AUC for predicting seven-year metastases in comparison to a risk model from the National Comprehensive Cancer Network (NCCN).